To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BUB3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
446 representative clones for gene BUB3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA447405 tongue, tumor tissue .a 1 to 567 7 to 575   tiling clone, capped   574/574
(100 %)
3 diff
(99.5 %id)
DA121465 cerebellum .a 5 to 371 2 to 368   capped   367/367
(100 %)
0 diff
(100 %id)
DB069451 testis .a 5 to 451 2 to 448   capped   447/447
(100 %)
1 diff
(99.8 %id)
DA269579 caudate nucleus .a 6 to 518 2 to 514   tiling clone, capped   513/513
(100 %)
1 diff
(99.9 %id)
DC378239   .a 421 to 978 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC363425   .a 422 to 962 1 to 541       541/541
(100 %)
0 diff
(100 %id)
DC363796   .a 429 to 954 1 to 530       530/530
(100 %)
2 diff
(99.7 %id)
DC300199   .a 450 to 1009 1 to 560       560/561
(99 %)
1 diff
(99.9 %id)
BP244693 Kidney .a 451 to 1042 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BI459998 testis .a 460 to 1306 1 to 849       847/849
(99 %)
17 diff
(98.0 %id)
AA353682   .a 461 to 789 1 to 329       329/329
(100 %)
4 diff
(98.8 %id)
DC297635   .a 465 to 1031 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
BM472336 embryonal carcinoma, cell line, testis .a 465 to 1094 1 to 630       630/968
(65 %)
9 diff
(99.1 %id)
BE890197 leiomyosarcoma, uterus .a 469 to 1129 1 to 665       665/1070
(62 %)
11 diff
(99.0 %id)
BG470576 eye, retinoblastoma .a 480 to 931 1 to 457       455/791
(57 %)
14 diff
(98.3 %id)
BQ440829 leiomyosarcoma, uterus .a 493 to 1355 1 to 866   tiling clone,   866/866
(100 %)
9 diff
(99.0 %id)
DB442947 testis .a 502 to 925 1 to 425       425/425
(100 %)
2 diff
(99.6 %id)
DC371385   .a 502 to 1080 1 to 579       579/579
(100 %)
0 diff
(100 %id)
TI_59385294   .a 511 to 1254 99 to 853       755/755
(100 %)
14 diff
(98.2 %id)
BU170507 eye, retinoblastoma .a 543 to 1424 1 to 900   tiling clone,   900/909
(99 %)
18 diff
(98.1 %id)
CA454084   .a 544 to 1414 1 to 883   tiling clone,   883/893
(98 %)
16 diff
(98.3 %id)
NM_004725.3   .b 1 to 2764 1 to 2764 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2764/2764
(100 %)
0 diff
(100 %id)
AK312546 tongue, tumor tissue .b 133 to 1229 1 to 1097 exact tiling clone,   1097/1097
(100 %)
0 diff
(100 %id)
AU120704 whole embryo, mainly body .b 157 to 1023 2 to 866   capped   865/865
(100 %)
14 diff
(98.4 %id)
BJ992659 hepatoblastoma .b 159 to 582 1 to 424       424/424
(100 %)
0 diff
(100 %id)
AF081496   .b 171 to 1411 17 to 1256 exact     1240/1259
(98 %)
1 diff
(100.0 %id)
AF047472 spleen; testis .b 172 to 2757 1 to 2585 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2585/2585
(100 %)
1 diff
(100.0 %id)
BC005138 Placenta, choriocarcinoma .b 172 to 1573 1 to 1402 exact available from MGC, AAA   1402/1402
(100 %)
1 diff
(100.0 %id)
BC022438 Brain, primitive neuroectodermal .b 180 to 1409 1 to 1230 exact available from MGC, AAA   1230/1230
(100 %)
2 diff
(99.9 %id)
BQ630964 insulinoma, Pancreas .b 189 to 782 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
AF053304   .b 206 to 2754 2 to 2553 exact     2552/2553
(99 %)
1 diff
(100.0 %id)
AL561423 B cells from Burkitt lymphoma .b 206 to 1120 29 to 945   fully sequenced,   917/945
(97 %)
2 diff
(99.8 %id)
BQ880293 dorsal root ganglia .b 454 to 1402 21 to 972       952/973
(97 %)
15 diff
(98.5 %id)
BQ879206 melanotic melanoma, cell line, skin .b 507 to 1286 799 to 15   AAA Submitted on the opposite strand 785/860
(91 %)
5 diff
(99.5 %id)
BY995738   .b 544 to 1289 28 to 772       745/772
(96 %)
0 diff
(100 %id)
BF346159 anaplastic oligodendroglioma with 1p/19qloss, brain .b 556 to 1302 1 to 741       741/957
(77 %)
19 diff
(98.1 %id)
BX394393 Neuroblastoma Cot 25-normalized .b 575 to 1505 947 to 28       920/984
(93 %)
15 diff
(98.5 %id)
W94718 heart .b 599 to 1027 1 to 430   fully sequenced,   430/430
(100 %)
3 diff
(99.4 %id)
BQ001992 lung, Metastatic Chondrosarcoma .b 655 to 1286 649 to 19   AAA   631/632
(99 %)
1 diff
(99.9 %id)
AI658896 Prostate .b 691 to 1286 621 to 27   AAA   595/600
(99 %)
6 diff
(99.0 %id)
AI376952   .b 702 to 1288 586 to 2       585/586
(99 %)
4 diff
(99.4 %id)
BF883179 lung_tumor .b 720 to 1229 1 to 510       510/510
(100 %)
12 diff
(97.7 %id)
BF821446 kidney_tumor .b 726 to 1272 542 to 1     Submitted on the opposite strand 542/543
(99 %)
11 diff
(98.0 %id)
AA778761 liver and spleen .b 732 to 1286 555 to 1       555/555
(100 %)
0 diff
(100 %id)
N42498 melanocyte .b 759 to 1027 1 to 269   fully sequenced,   269/269
(100 %)
1 diff
(99.7 %id)
BF970126 adrenal cortex carcinoma, cell line, adrenal gland .b 761 to 1410 1 to 646   AAA   646/646
(100 %)
5 diff
(99.3 %id)
BF879251 lung_tumor .b 785 to 1268 491 to 11     Submitted on the opposite strand 481/491
(97 %)
0 diff
(100 %id)
DA830171 placenta .b 798 to 1599 2 to 812   capped   811/820
(98 %)
23 diff
(97.2 %id)
BG613236 embryonal carcinoma, testis .b 801 to 1347 1 to 548       548/549
(99 %)
3 diff
(99.5 %id)
BF883169 lung_tumor .b 812 to 1285 475 to 1     Submitted on the opposite strand 475/475
(100 %)
4 diff
(99.2 %id)
CR615326 Placenta Cot 25-normalized .b 823 to 2716 1 to 1894       1894/1894
(100 %)
0 diff
(100 %id)
AL544475 placenta, Placenta Cot 25-normalized .b 823 to 1754 1 to 920   fully sequenced,   920/920
(100 %)
1 diff
(99.9 %id)
BF879181 lung_tumor .b 829 to 1232 404 to 1     Submitted on the opposite strand 404/404
(100 %)
2 diff
(99.6 %id)
AI051192 liver and spleen .b 837 to 1286 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
BQ309309 breast .b 844 to 1447 613 to 9       605/618
(97 %)
6 diff
(99.1 %id)
BI260391 cervical carcinoma cell line, cervix .b 851 to 1547 1 to 700       700/702
(99 %)
8 diff
(98.9 %id)
AL583362 B cells from Burkitt lymphoma .b 857 to 1554 1 to 699       699/705
(99 %)
3 diff
(99.6 %id)
BF928220 nervous_tumor .b 858 to 1265 409 to 3     Submitted on the opposite strand 407/409
(99 %)
6 diff
(98.6 %id)
BQ305456 breast .b 858 to 1449 596 to 5       592/596
(99 %)
14 diff
(97.7 %id)
BQ307182 breast .b 873 to 1449 582 to 8       575/582
(98 %)
6 diff
(99.0 %id)
AA677617 liver and spleen .b 887 to 1284 399 to 1       399/403
(99 %)
5 diff
(98.8 %id)
AA609567   .b 894 to 1286 396 to 4       393/396
(99 %)
0 diff
(100 %id)
CN281223 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 930 to 1574 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
DA263198 caudate nucleus .b 933 to 1491 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
CN281218 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 941 to 1666 1 to 727       727/727
(100 %)
2 diff
(99.8 %id)
AA188115   .b 944 to 1411 472 to 4     Submitted on the opposite strand 469/474
(98 %)
5 diff
(99.0 %id)
CN281206 embryonic stem cells, DMSO-treated H9 cellline .b 957 to 1484 2 to 528       527/528
(99 %)
6 diff
(98.9 %id)
BU183204 bone marrow, from acute myelogenous leukemia .b 958 to 1601 1 to 650       650/820
(79 %)
27 diff
(96.8 %id)
BQ582237 insulinoma, Pancreas .b 963 to 1592 649 to 20   AAA   630/630
(100 %)
1 diff
(99.9 %id)
W94633 heart .b 966 to 1409 450 to 4   fully sequenced,   447/450
(99 %)
2 diff
(99.6 %id)
BG776513 lung, mucoepidermoid carcinoma .b 975 to 1730 1 to 758       758/758
(100 %)
12 diff
(98.5 %id)
N29806 melanocyte .b 983 to 1410 428 to 1   fully sequenced,   428/428
(100 %)
0 diff
(100 %id)
BF823271 kidney_tumor .b 987 to 1273 287 to 1     Submitted on the opposite strand 287/288
(99 %)
3 diff
(99.0 %id)
BQ310429 breast .b 994 to 1364 376 to 1       376/396
(94 %)
28 diff
(93.0 %id)
BQ305675 breast .b 1003 to 1449 452 to 8       445/452
(98 %)
6 diff
(98.7 %id)
H38880 liver and spleen .b 1009 to 1541 1 to 551       551/551
(100 %)
29 diff
(94.8 %id)
BX116075 liver and spleen .b 1010 to 1716 1 to 707       707/707
(100 %)
0 diff
(100 %id)
BQ307691 breast .b 1023 to 1362 342 to 1       342/342
(100 %)
22 diff
(93.6 %id)
BY996286   .b 1038 to 1695 21 to 678       658/678
(97 %)
0 diff
(100 %id)
DA828759 placenta .b 1045 to 1792 2 to 761   capped   760/798
(95 %)
24 diff
(97.0 %id)
AA405955.
matches multiple genes
  .b 1071 to 1411 1 to 341     also hits gene slytarbu 341/341
(100 %)
0 diff
(100 %id)
BG505365 embryonal carcinoma, testis .b 1080 to 1851 1 to 774       774/774
(100 %)
20 diff
(97.5 %id)
AL582633 B cells from Burkitt lymphoma .b 1090 to 2081 1033 to 40   fully sequenced,   992/1031
(96 %)
25 diff
(97.6 %id)
BQ307700 breast .b 1095 to 1378 287 to 2       284/292
(97 %)
7 diff
(97.7 %id)
AI214882   .b 1104 to 1411 310 to 3       308/310
(99 %)
0 diff
(100 %id)
AA405689.
matches multiple genes
  .b 1105 to 1411 309 to 3     also hits gene klawkaw 307/309
(99 %)
0 diff
(100 %id)
CN281208 embryonic stem cells, DMSO-treated H9 cellline .b 1114 to 1505 392 to 1     Submitted on the opposite strand 392/392
(100 %)
2 diff
(99.5 %id)
BM705763 eye, lens .b 1115 to 1627 1 to 513     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
BU194070 melanotic melanoma, skin .b 1126 to 1974 12 to 866       855/891
(95 %)
29 diff
(96.8 %id)
CV395574 lung_tumor .b 1127 to 1287 1 to 164       164/165
(99 %)
19 diff
(88.5 %id)
BG612230 adenocarcinoma, Prostate .b 1155 to 1935 1 to 797       797/816
(97 %)
35 diff
(95.8 %id)
DA358822 subthalamic nucleus .b 1164 to 1743 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
FN159477 breast carcinoma .b 1178 to 1273 1 to 95       95/99
(95 %)
2 diff
(98.0 %id)
BM752410 Ascites, stomach .b 1179 to 1441 1 to 264       264/264
(100 %)
3 diff
(98.9 %id)
BF244670 brain, glioblastoma .b 1214 to 1891 50 to 718       669/834
(80 %)
33 diff
(96.1 %id)
BQ307230 breast .b 1218 to 1449 255 to 25       231/255
(90 %)
0 diff
(100 %id)
AA251986 germinal center B cell .b 1230 to 1595 1 to 365       365/365
(100 %)
3 diff
(99.2 %id)
AW770032 lymph node, lymphoma, follicular mixed small and largecell .b 1242 to 1411 175 to 7       169/175
(96 %)
0 diff
(100 %id)
EH317334   .b 1253 to 1303 1 to 51       51/51
(100 %)
0 diff
(100 %id)
BE567042 bladder, carcinoma, cell line .b 1271 to 1887 1 to 615       615/762
(80 %)
20 diff
(97.4 %id)
BG533595 Liver .b 1291 to 2009 1 to 719       719/720
(99 %)
14 diff
(98.1 %id)
BG613433 embryonal carcinoma, testis .b 1293 to 1979 1 to 702       702/904
(77 %)
35 diff
(96.2 %id)
TI_57193415   .b 1293 to 1952 52 to 710       659/659
(100 %)
5 diff
(99.3 %id)
BI861921 breast, mammary adenocarcinoma, cell line .b 1295 to 1952 1 to 657       657/657
(100 %)
5 diff
(99.3 %id)
BG503387 embryonal carcinoma, testis .b 1303 to 2058 1 to 757       757/757
(100 %)
12 diff
(98.5 %id)
CN281204 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1307 to 2029 1 to 722       722/722
(100 %)
4 diff
(99.5 %id)
CB134834 Liver .b 1320 to 1996 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
BQ439181 embryonal carcinoma, cell line, testis .b 1344 to 2149 1 to 818       818/909
(89 %)
14 diff
(98.5 %id)
CF122371 CNCAP(3)T-225 cell line, Prostate .b 1361 to 1964 1 to 605       605/615
(98 %)
8 diff
(98.7 %id)
TI_154181941   .b 1368 to 2154 77 to 858       782/905
(86 %)
34 diff
(96.3 %id)
CA335086 posterior tongue (pooled) .b 1376 to 2019 1 to 645       645/645
(100 %)
3 diff
(99.6 %id)
BU688718 lung, Primary Lung Epithelial Cells .b 1377 to 2078 1 to 703     Submitted on the opposite strand 703/703
(100 %)
3 diff
(99.6 %id)
FN134132 breast carcinoma .b 1401 to 1505 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
CN281216 embryonic stem cells, DMSO-treated H9 cellline .b 1407 to 1793 1 to 387       387/387
(100 %)
0 diff
(100 %id)
BF968661 adrenal cortex carcinoma, cell line, adrenal gland .b 1409 to 2152 1 to 748       748/814
(91 %)
16 diff
(98.1 %id)
BG504782 embryonal carcinoma, testis .b 1443 to 2119 1 to 682       682/839
(81 %)
9 diff
(99.0 %id)
BU147541 sciatic nerve .b 1474 to 2348 1 to 876       876/878
(99 %)
12 diff
(98.7 %id)
BU630884 cell lines, Chondrosarcoma .b 1487 to 2136 668 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 650/650
(100 %)
3 diff
(99.6 %id)
EH344315   .b 1489 to 1585 1 to 97       97/99
(97 %)
1 diff
(99.0 %id)
CB112319 Liver .b 1501 to 2037 1 to 537       537/537
(100 %)
1 diff
(99.9 %id)
BF213097 bone marrow, from acute myelogenous leukemia .b 1526 to 2169 1 to 631       631/859
(73 %)
28 diff
(96.8 %id)
AW971576   .b 1529 to 2129 601 to 1     Submitted on the opposite strand 601/603
(99 %)
6 diff
(99.1 %id)
BM471295 leiomyosarcoma, uterus .b 1529 to 2130 651 to 42   AAA Submitted on the opposite strand 610/1246
(48 %)
15 diff
(98.8 %id)
TI_57244684   .b 1531 to 2277 32 to 767       736/767
(95 %)
0 diff
(100 %id)
BI917394 brain .b 1533 to 2277 1 to 734       734/734
(100 %)
11 diff
(98.6 %id)
BM751206 Ascites, stomach .b 1541 to 2121 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
AA297948 Prostate .b 1542 to 1923 1 to 390       390/390
(100 %)
10 diff
(97.5 %id)
FN083582 breast carcinoma .b 1551 to 1636 85 to 1     Submitted on the opposite strand 85/86
(98 %)
1 diff
(98.9 %id)
TI_57171350   .b 1594 to 2363 53 to 834       782/1049
(74 %)
23 diff
(97.9 %id)
BI830511 brain, medulla .b 1597 to 2363 1 to 779       779/994
(78 %)
21 diff
(97.9 %id)
AI922582 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1623 to 2130 508 to 1       508/508
(100 %)
1 diff
(99.9 %id)
BF691649 melanotic melanoma, high MDR, skin .b 1631 to 2055 1 to 425       425/425
(100 %)
0 diff
(100 %id)
BE895746 melanotic melanoma, skin .b 1633 to 2369 1 to 724       724/917
(78 %)
26 diff
(97.2 %id)
AA847597 carcinoid, lung .b 1634 to 2133 500 to 1       500/500
(100 %)
0 diff
(100 %id)
BU734965 eye, lens .b 1644 to 2130 505 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
CN281219 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1646 to 2340 19 to 715       697/715
(97 %)
0 diff
(100 %id)
DB543369 hippocampus .b 1657 to 2130 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
FN123207 breast carcinoma .b 1664 to 1771 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
BF978330 melanotic melanoma, high MDR, skin .b 1683 to 2372 1 to 688       688/847
(81 %)
14 diff
(98.4 %id)
BF690632 melanotic melanoma, high MDR, skin .b 1683 to 2370 1 to 679       679/852
(79 %)
20 diff
(97.7 %id)
BF690894 melanotic melanoma, high MDR, skin .b 1683 to 2345 1 to 659       659/660
(99 %)
21 diff
(96.9 %id)
BF691219 melanotic melanoma, high MDR, skin .b 1683 to 2341 1 to 658       658/779
(84 %)
22 diff
(97.2 %id)
BJ992660 hepatoblastoma .b 1710 to 2098 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AI127577 uterus .b 1712 to 2133 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AI439456 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1713 to 2130 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
BF106977 placenta .b 1718 to 2366 1 to 625       625/795
(78 %)
30 diff
(96.3 %id)
AL570688 placenta, Placenta Cot 25-normalized .b 1724 to 2717 987 to 1   fully sequenced,   987/987
(100 %)
6 diff
(99.4 %id)
AW880573 ovary .b 1727 to 2256 531 to 2       530/531
(99 %)
0 diff
(100 %id)
BF215176 bone marrow, from acute myelogenous leukemia .b 1730 to 2363 1 to 625       625/685
(91 %)
19 diff
(97.3 %id)
BE972510 testis .b 1747 to 2385 1 to 619       619/621
(99 %)
23 diff
(96.3 %id)
CB128926 Liver .b 1748 to 2286 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
BF665515 brain, primitive neuroectoderm .b 1751 to 2416 1 to 652       652/659
(98 %)
14 diff
(97.9 %id)
CN281212 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1753 to 2130 426 to 49   AAA Submitted on the opposite strand 378/378
(100 %)
0 diff
(100 %id)
BG484348 lung .b 1756 to 2498 1 to 741       741/742
(99 %)
23 diff
(97.0 %id)
BG114372 Bone, osteosarcoma, cell line .b 1762 to 2363 1 to 598       598/1055
(56 %)
13 diff
(98.8 %id)
FN131750 breast carcinoma .b 1767 to 1888 124 to 1     Submitted on the opposite strand 124/124
(100 %)
2 diff
(98.4 %id)
CN281210 embryonic stem cells, DMSO-treated H9 cellline .b 1768 to 2130 373 to 11   AAA Submitted on the opposite strand 363/374
(97 %)
6 diff
(98.4 %id)
AA448967   .b 1777 to 2241 1 to 465       465/465
(100 %)
0 diff
(100 %id)
AA809500 germinal center B cell .b 1779 to 2135 361 to 5       357/361
(98 %)
0 diff
(100 %id)
AA251758 germinal center B cell .b 1795 to 2130 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI703461 carcinoid, lung .b 1823 to 2133 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
AA322426 brain, cerebellum .b 1826 to 2095 1 to 270       270/270
(100 %)
0 diff
(100 %id)
H38804 liver and spleen .b 1847 to 2132 288 to 1       288/290
(99 %)
4 diff
(98.7 %id)
CN485324 eye .b 1866 to 2493 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
AA377316 small intestine .b 1872 to 2194 1 to 323       323/323
(100 %)
2 diff
(99.4 %id)
AW964013   .b 1873 to 2552 1 to 682       682/683
(99 %)
5 diff
(99.3 %id)
FN069824 breast carcinoma .b 1878 to 1968 97 to 10     Submitted on the opposite strand 88/97
(90 %)
0 diff
(100 %id)
TI_149310868   .b 1895 to 2757 944 to 80   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 865/1010
(85 %)
23 diff
(97.8 %id)
BE710281 head_neck .b 1923 to 2111 188 to 1       188/188
(100 %)
1 diff
(99.5 %id)
CV805300 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1952 to 2748 802 to 3     Submitted on the opposite strand 800/882
(90 %)
0 diff
(100 %id)
FN122176 breast carcinoma .b 1960 to 2070 1 to 108       108/108
(100 %)
4 diff
(96.3 %id)
CD657029 Embryonic Stem cells .b 1964 to 2759 847 to 55     Submitted on the opposite strand 793/903
(87 %)
0 diff
(100 %id)
TI_149276532   .b 1966 to 2757 872 to 91   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 782/852
(91 %)
15 diff
(98.3 %id)
CN281224 embryonic stem cells, DMSO-treated H9 cellline .b 1976 to 2600 1 to 625       625/625
(100 %)
3 diff
(99.6 %id)
CV813566 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1977 to 2754 784 to 1     Submitted on the opposite strand 784/888
(88 %)
21 diff
(97.7 %id)
TI_154109469   .b 1979 to 2757 870 to 92   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 779/995
(78 %)
5 diff
(99.5 %id)
TI_149314683   .b 1992 to 2756 836 to 87   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 750/933
(80 %)
33 diff
(96.5 %id)
AA280260 germinal center B cell .b 2048 to 2364 1 to 317       317/317
(100 %)
0 diff
(100 %id)
FN108233 breast carcinoma .b 2052 to 2146 1 to 93       93/100
(93 %)
3 diff
(97.0 %id)
FN100340 breast carcinoma .b 2071 to 2133 63 to 1     Submitted on the opposite strand 63/64
(98 %)
0 diff
(100 %id)
AA837638 ovary .b 2078 to 2223 146 to 1       146/150
(97 %)
1 diff
(99.4 %id)
AA829577 ovary .b 2078 to 2223 146 to 1       146/150
(97 %)
0 diff
(100 %id)
BE905049 epithelioid carcinoma, Pancreas .b 2101 to 2756 670 to 8     Submitted on the opposite strand 663/729
(90 %)
0 diff
(100 %id)
BM977194 lung, Primary Lung Epithelial Cells .b 2107 to 2757 671 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 653/653
(100 %)
5 diff
(99.3 %id)
BF791799 adrenal cortex carcinoma, cell line, adrenal gland .b 2111 to 2759 1 to 648       648/668
(97 %)
7 diff
(99.0 %id)
AW392690 stomach .b 2118 to 2638 537 to 17       521/557
(93 %)
0 diff
(100 %id)
AW392748 stomach .b 2118 to 2629 511 to 1       511/517
(98 %)
8 diff
(98.5 %id)
CB854006 lung, Primary Lung Epithelial Cells .b 2122 to 2757 655 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 637/637
(100 %)
3 diff
(99.6 %id)
BM989334 Fibrosarcoma .b 2131 to 2764 653 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 635/635
(100 %)
2 diff
(99.7 %id)
FN169723 breast carcinoma .b 2132 to 2210 1 to 79       79/79
(100 %)
5 diff
(93.7 %id)
CA447924 Chondrosarcoma, Left Pelvis .b 2150 to 2757 626 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 608/608
(100 %)
0 diff
(100 %id)
DB373356 placenta .b 2164 to 2757 592 to 1       592/595
(99 %)
13 diff
(97.9 %id)
TI_159715255   .b 2179 to 2757 677 to 100   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 578/1073
(53 %)
4 diff
(99.7 %id)
AU146700 whole embryo, mainly body .b 2199 to 2754 553 to 4       550/553
(99 %)
0 diff
(100 %id)
BJ992523 hepatoblastoma .b 2214 to 2722 507 to 1       507/507
(100 %)
2 diff
(99.7 %id)
FN143159 breast carcinoma .b 2227 to 2318 1 to 90       90/92
(97 %)
5 diff
(94.6 %id)
DB570045 hypothalamus .b 2246 to 2757 1 to 510     Submitted on the opposite strand 510/511
(99 %)
3 diff
(99.5 %id)
AA282569 germinal center B cell .b 2248 to 2619 1 to 372     Submitted on the opposite strand 372/372
(100 %)
0 diff
(100 %id)
CB851366 lung, Primary Lung Epithelial Cells .b 2255 to 2759 5 to 508     Submitted on the opposite strand 504/557
(90 %)
7 diff
(98.8 %id)
DB577486 hypothalamus .b 2259 to 2757 1 to 497     Submitted on the opposite strand 497/498
(99 %)
3 diff
(99.4 %id)
AI457622 pooled .b 2272 to 2756 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AW392693 stomach .b 2273 to 2638 387 to 23       365/387
(94 %)
0 diff
(100 %id)
DB375215 placenta .b 2278 to 2757 477 to 1       477/480
(99 %)
5 diff
(99.0 %id)
DB521507 testis .b 2283 to 2757 1 to 473     Submitted on the opposite strand 473/473
(100 %)
2 diff
(99.6 %id)
DB570954 hypothalamus .b 2289 to 2757 1 to 467     Submitted on the opposite strand 467/468
(99 %)
2 diff
(99.6 %id)
DB526740 testis .b 2299 to 2757 1 to 457     Submitted on the opposite strand 457/457
(100 %)
1 diff
(99.8 %id)
DB566629 hypothalamus .b 2305 to 2757 1 to 451     Submitted on the opposite strand 451/452
(99 %)
3 diff
(99.4 %id)
DB542049 hippocampus .b 2307 to 2757 1 to 449   AAA Submitted on the opposite strand 449/449
(100 %)
3 diff
(99.4 %id)
DB535153 hippocampus .b 2313 to 2756 1 to 444     Submitted on the opposite strand 444/444
(100 %)
1 diff
(99.8 %id)
DB538371 hippocampus .b 2320 to 2757 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
AJ709263 heart .b 2330 to 2752 423 to 1     Submitted on the opposite strand 423/423
(100 %)
3 diff
(99.3 %id)
DB512024 testis .b 2333 to 2759 1 to 425     Submitted on the opposite strand 425/428
(99 %)
4 diff
(99.1 %id)
DB532610 hippocampus .b 2336 to 2757 1 to 422     Submitted on the opposite strand 422/422
(100 %)
0 diff
(100 %id)
DB534263 hippocampus .b 2343 to 2754 1 to 414     Submitted on the opposite strand 414/414
(100 %)
4 diff
(99.1 %id)
AA282681 germinal center B cell .b 2353 to 2746 394 to 1     Submitted on the opposite strand 394/394
(100 %)
0 diff
(100 %id)
BG943928 blood .b 2363 to 2645 23 to 305       283/305
(92 %)
0 diff
(100 %id)
DW429581 Liver .b 2366 to 2757 399 to 8       392/399
(98 %)
0 diff
(100 %id)
AI292029 carcinoid, lung .b 2374 to 2750 1 to 377     Submitted on the opposite strand 377/377
(100 %)
0 diff
(100 %id)
FN172204 breast carcinoma .b 2377 to 2481 106 to 2     Submitted on the opposite strand 105/110
(95 %)
0 diff
(100 %id)
AA236762 germinal center B cell .b 2382 to 2759 1 to 377       377/382
(98 %)
2 diff
(99.5 %id)
AA629106   .b 2382 to 2580 1 to 199     Submitted on the opposite strand 199/199
(100 %)
0 diff
(100 %id)
AA281601 germinal center B cell .b 2386 to 2757 372 to 1       372/372
(100 %)
0 diff
(100 %id)
FN051572 breast carcinoma .b 2394 to 2503 110 to 1     Submitted on the opposite strand 110/110
(100 %)
0 diff
(100 %id)
FN150635 breast carcinoma .b 2403 to 2506 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
DB537199 hippocampus .b 2412 to 2755 1 to 344     Submitted on the opposite strand 344/346
(99 %)
4 diff
(98.9 %id)
TI_151703766   .b 2417 to 2757 437 to 97   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 341/1373
(24 %)
0 diff
(100 %id)
NM_001007793.2   .c 1 to 1537 1 to 1537 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1537/1537
(100 %)
0 diff
(100 %id)
BP328027 prostata .c 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
DC419319 stomach, tumor tissue .c 15 to 576 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DC299127   .c 43 to 623 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC424926   .c 119 to 595 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BG773481 testis .c 121 to 893 1 to 772       772/772
(100 %)
11 diff
(98.6 %id)
DA111035 cerebellum .c 123 to 712 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DB230812 trachea .c 123 to 727 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DA501020 brain .c 126 to 681 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA393418 thalamus .c 127 to 720 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA093590 cerebellum .c 128 to 762 2 to 636   capped   635/635
(100 %)
0 diff
(100 %id)
DA379648 thalamus .c 128 to 666 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA549423   .c 128 to 701 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BP225023   .c 130 to 711 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA016943 adrenal gland .c 134 to 554 2 to 422   capped   421/421
(100 %)
0 diff
(100 %id)
DA196763 amygdala .c 134 to 697 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA439753 tongue, tumor tissue .c 134 to 707 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BI546994 brain, hippocampus .c 136 to 935 1 to 798       798/891
(89 %)
25 diff
(97.2 %id)
TI_44167674   .c 138 to 935 124 to 919       796/1012
(78 %)
21 diff
(98.0 %id)
BG616331 embryonal carcinoma, testis .c 140 to 972 1 to 833       833/838
(99 %)
27 diff
(96.8 %id)
BG615476 embryonal carcinoma, testis .c 140 to 930 1 to 781       781/797
(97 %)
22 diff
(97.3 %id)
DA314717 hippocampus .c 144 to 705 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CB112673 Liver .c 144 to 618 1 to 475       475/475
(100 %)
0 diff
(100 %id)
DA165732 amygdala .c 145 to 718 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA413328 thalamus .c 145 to 681 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA484393 brain .c 145 to 674 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BG771564 testis .c 145 to 883 1 to 740       740/753
(98 %)
9 diff
(98.9 %id)
DA113721 cerebellum .c 146 to 679 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA785515 brain .c 146 to 720 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CD110316 placenta, pre-eclamptic placenta .c 148 to 878 28 to 763       736/771
(95 %)
11 diff
(98.6 %id)
BP367780 thymus .c 150 to 734 1 to 585       585/585
(100 %)
0 diff
(100 %id)
DA173387 amygdala .c 151 to 709 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA473343   .c 151 to 709 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA529300 brain .c 151 to 762 2 to 613   capped   612/612
(100 %)
0 diff
(100 %id)
DA559607 heart .c 151 to 700 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BG532073 embryonal carcinoma, testis .c 151 to 983 1 to 836       836/884
(94 %)
22 diff
(97.6 %id)
DA608446   .c 151 to 711 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA617386   .c 151 to 727 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA803215 brain .c 151 to 689 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA941335 Spleen .c 151 to 733 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB129068 thymus .c 151 to 709 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA012459 adrenal gland .c 152 to 628 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
DA046243 bladder .c 152 to 714 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA241618 brain .c 152 to 750 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA544929   .c 152 to 714 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BG530417 embryonal carcinoma, testis .c 152 to 754 1 to 603       603/603
(100 %)
0 diff
(100 %id)
DA888888   .c 152 to 705 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB135518 thymus .c 152 to 713 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA094056 cerebellum .c 153 to 714 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BI462447 testis .c 153 to 891 1 to 736       736/736
(100 %)
8 diff
(99.0 %id)
BI464380 testis .c 153 to 927 1 to 780       780/805
(96 %)
13 diff
(98.4 %id)
DA795778 brain .c 153 to 403 2 to 252   capped   251/251
(100 %)
0 diff
(100 %id)
DB277550 uterus .c 153 to 695 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BG720782 testis .c 154 to 930 1 to 778       778/778
(100 %)
9 diff
(98.9 %id)
CB992746 placenta, pre-eclamptic placenta .c 154 to 915 24 to 791       768/791
(97 %)
8 diff
(99.0 %id)
DN989403 brain, whole brain .c 154 to 868 1 to 715       715/715
(100 %)
6 diff
(99.2 %id)
DA512121 brain .c 156 to 688 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BG537606 lung .c 156 to 889 1 to 733       733/738
(99 %)
15 diff
(98.0 %id)
BU932920 mixed (pool of 40 RNAs) .c 157 to 967 1 to 812       812/812
(100 %)
10 diff
(98.8 %id)
BU934225 mixed (pool of 40 RNAs) .c 157 to 908 1 to 761       761/795
(95 %)
19 diff
(97.7 %id)
BU935030 mixed (pool of 40 RNAs) .c 157 to 886 1 to 737       737/779
(94 %)
22 diff
(97.2 %id)
BP374219 umbilical cord .c 157 to 738 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA020425   .c 158 to 725 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA483584 brain .c 158 to 895 2 to 736   capped   735/736
(99 %)
7 diff
(99.1 %id)
BG505995 embryonal carcinoma, testis .c 158 to 927 1 to 769       769/769
(100 %)
19 diff
(97.6 %id)
BG496249 lung, mucoepidermoid carcinoma .c 158 to 897 1 to 741       741/743
(99 %)
13 diff
(98.3 %id)
BG718407 testis .c 158 to 926 1 to 770       770/770
(100 %)
8 diff
(99.0 %id)
BU935493 mixed (pool of 40 RNAs) .c 158 to 879 1 to 728       728/767
(94 %)
25 diff
(96.8 %id)
DA788794 brain .c 158 to 660 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
DB139795 thymus .c 158 to 691 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
AU142396   .c 158 to 998 2 to 842   capped   841/862
(97 %)
7 diff
(99.2 %id)
DA186079 amygdala .c 159 to 688 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BP213372 cerebrum .c 159 to 729 1 to 571       571/571
(100 %)
0 diff
(100 %id)
AL711035 human skeletal muscle .c 159 to 556 1 to 398       398/398
(100 %)
0 diff
(100 %id)
BJ991209 hepatoblastoma .c 159 to 744 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BG504215 embryonal carcinoma, testis .c 159 to 974 1 to 817       817/840
(97 %)
37 diff
(95.6 %id)
DA019309   .c 160 to 714 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA080650 cerebellum .c 160 to 707 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA194679 amygdala .c 160 to 756 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA199221 brain .c 160 to 699 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA344190 substantia nigra .c 160 to 735 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA497814 brain .c 160 to 734 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA502144 brain .c 160 to 727 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA556400   .c 160 to 728 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA605119   .c 160 to 705 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AV763133 bone marrow .c 160 to 914 1 to 750       750/788
(95 %)
17 diff
(97.9 %id)
DA785403 brain .c 160 to 618 2 to 460   capped   459/459
(100 %)
0 diff
(100 %id)
DA811292 brain .c 160 to 733 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB132692 thymus .c 160 to 705 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DB158715 thymus .c 160 to 750 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DB216324 trachea .c 160 to 698 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB224662 trachea .c 160 to 713 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB249187 uterus .c 160 to 704 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB280205 uterus .c 160 to 686 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA095102 cerebellum .c 161 to 714 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BG502456 embryonal carcinoma, testis .c 167 to 894 1 to 728       728/728
(100 %)
7 diff
(99.1 %id)
BM710835 eye, fetal eyes .c 168 to 735 1 to 568     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 568/568
(100 %)
0 diff
(100 %id)
DA495342 brain .c 169 to 707 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
FN087377 breast carcinoma .c 170 to 278 109 to 1     Submitted on the opposite strand 109/109
(100 %)
0 diff
(100 %id)
BQ647173 hepatocellular carcinoma, cell line, Liver .c 170 to 997 21 to 849       829/984
(84 %)
6 diff
(99.4 %id)
TI_154178713   .c 170 to 1040 75 to 930       856/857
(99 %)
29 diff
(96.7 %id)
BM721251 eye, fetal eye .c 170 to 849 1 to 680   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 680/680
(100 %)
0 diff
(100 %id)
AF047473 spleen; testis .c 172 to 1530 1 to 1358 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1358/1358
(100 %)
1 diff
(100.0 %id)
BQ644973 hepatocellular carcinoma, cell line, Liver .c 172 to 992 1 to 829       829/970
(85 %)
28 diff
(97.2 %id)
BI459607 testis .c 177 to 978 1 to 802       802/802
(100 %)
9 diff
(98.9 %id)
DA405325 thalamus .c 178 to 737 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA600663   .c 178 to 714 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BU945607 mixed (pool of 40 RNAs) .c 178 to 928 1 to 757       757/821
(92 %)
8 diff
(99.1 %id)
BG535231 lung .c 179 to 922 1 to 758       758/758
(100 %)
26 diff
(96.6 %id)
BG776751 lung, mucoepidermoid carcinoma .c 179 to 932 1 to 753       753/755
(99 %)
9 diff
(98.9 %id)
BG615955 embryonal carcinoma, testis .c 181 to 921 1 to 751       748/753
(99 %)
12 diff
(98.5 %id)
DA543210   .c 182 to 734 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BQ054086 blood, natural killer cells, cell line .c 185 to 1070 24 to 921       896/1094
(81 %)
17 diff
(98.5 %id)
BQ054017 blood, natural killer cells, cell line .c 187 to 995 1 to 817       817/1042
(78 %)
18 diff
(98.3 %id)
BE792271 lung, small cell carcinoma .c 190 to 977 1 to 785       785/833
(94 %)
24 diff
(97.2 %id)
BG104939 adrenal cortex carcinoma, cell line, adrenal gland .c 193 to 921 1 to 731       731/973
(75 %)
20 diff
(98.0 %id)
CX787102 human embryonic stem cells .c 193 to 950 1 to 758       758/758
(100 %)
0 diff
(100 %id)
BQ723773 sympathetic trunk .c 195 to 1042 1 to 853       851/854
(99 %)
11 diff
(98.8 %id)
CV809937 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 195 to 968 1 to 777       777/854
(90 %)
23 diff
(97.4 %id)
BE793093 lung, small cell carcinoma .c 197 to 932 1 to 727       727/805
(90 %)
13 diff
(98.4 %id)
CX869203 embryonic stem .c 197 to 981 1 to 785     Submitted on the opposite strand 785/785
(100 %)
0 diff
(100 %id)
CX163357 human embryonic stem cells differentiated toan early endodermal cell type .c 197 to 1036 1 to 840     Submitted on the opposite strand 840/840
(100 %)
0 diff
(100 %id)
CN281221 embryonic stem cells, cell lines H1, H7, andH9 .c 200 to 820 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BG259872 bladder, transitional cell papilloma, cell line .c 204 to 810 1 to 607       607/608
(99 %)
2 diff
(99.7 %id)
CV815046 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 206 to 998 35 to 832       798/841
(94 %)
17 diff
(98.0 %id)
BF034075 adenocarcinoma, ovary .c 214 to 997 1 to 776       776/884
(87 %)
38 diff
(95.8 %id)
BU173487 leiomyosarcoma, uterus .c 214 to 1064 1 to 863       863/868
(99 %)
13 diff
(98.6 %id)
BE732977 choriocarcinoma, placenta .c 218 to 1081 1 to 865       866/1004
(86 %)
31 diff
(97.0 %id)
AA236129 germinal center B cell .c 228 to 391 1 to 164     Submitted on the opposite strand 164/164
(100 %)
0 diff
(100 %id)
AA290942 ovarian tumor, ovary .c 228 to 319 1 to 92     Submitted on the opposite strand 92/92
(100 %)
0 diff
(100 %id)
AA421810 ovarian tumor, ovary .c 228 to 615 1 to 388     Submitted on the opposite strand 388/388
(100 %)
0 diff
(100 %id)
AA512921 breast .c 228 to 698 1 to 471     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
AA609114   .c 228 to 615 1 to 388     Submitted on the opposite strand 388/388
(100 %)
0 diff
(100 %id)
AA836564 germinal center B cell .c 229 to 601 1 to 373       373/373
(100 %)
0 diff
(100 %id)
BM010471 amelanotic melanoma, cell line, skin .c 233 to 977 1 to 756       756/756
(100 %)
15 diff
(98.1 %id)
BQ216823 large cell carcinoma, lung .c 241 to 998 1 to 762       762/889
(85 %)
21 diff
(97.7 %id)
CV025727 mixed .c 243 to 900 1 to 655       655/655
(100 %)
3 diff
(99.6 %id)
TI_1948085374   .c 243 to 1006 130 to 897       768/1448
(53 %)
23 diff
(98.5 %id)
TI_1948221529   .c 243 to 1196 122 to 1086   fully sequenced,   965/1086
(88 %)
42 diff
(96.2 %id)
TI_1948221878   .c 243 to 1051 122 to 937       816/1341
(60 %)
14 diff
(99.0 %id)
TI_154146920   .c 244 to 659 80 to 495       416/416
(100 %)
0 diff
(100 %id)
BM753853 stomach .c 251 to 678 1 to 428       428/428
(100 %)
0 diff
(100 %id)
BM766214 stomach .c 251 to 703 1 to 453       453/453
(100 %)
0 diff
(100 %id)
CN281227 embryonic stem cells, cell lines H1, H7, andH9 .c 293 to 647 1 to 355       355/355
(100 %)
0 diff
(100 %id)
AA814414 germinal center B cell .c 300 to 926 1 to 627     Submitted on the opposite strand 627/627
(100 %)
0 diff
(100 %id)
AA811838 germinal center B cell .c 300 to 725 1 to 426     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
FN145161 breast carcinoma .c 315 to 401 1 to 87       87/87
(100 %)
0 diff
(100 %id)
BU506853 leiomyosarcoma, uterus .c 323 to 1160 1 to 847       847/898
(94 %)
17 diff
(98.2 %id)
BU153240 large cell carcinoma, lung .c 331 to 1100 1 to 778       778/933
(83 %)
22 diff
(97.7 %id)
BG260092 bladder, transitional cell papilloma, cell line .c 338 to 1116 1 to 797       736/966
(76 %)
13 diff
(98.7 %id)
BM805903 brain, hippocampus .c 358 to 1213 11 to 870       860/1090
(78 %)
11 diff
(99.0 %id)
DA545179   .c 368 to 938 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
EY198527 intestinal (Lauren) gastric adenocarcinoma, stomach .c 399 to 799 1 to 401       401/401
(100 %)
0 diff
(100 %id)
DA030752   .c 419 to 951 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA499769 brain .c 435 to 887 2 to 454   capped   453/453
(100 %)
0 diff
(100 %id)
BG683238 brain, neuroblastoma, cell line .c 461 to 1206 1 to 747   fully sequenced,   747/747
(100 %)
2 diff
(99.8 %id)
CB129513 Liver .c 471 to 1035 1 to 565       565/565
(100 %)
0 diff
(100 %id)
CN281225 embryonic stem cells, DMSO-treated H9 cellline .c 476 to 1141 1 to 666       666/666
(100 %)
0 diff
(100 %id)
DA597889   .c 477 to 1016 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BU932977 mixed (pool of 40 RNAs) .c 492 to 1321 1 to 835       835/835
(100 %)
16 diff
(98.1 %id)
BG118120 adenocarcinoma, cell line, Liver .c 493 to 1215 1 to 725       725/1118
(64 %)
15 diff
(98.7 %id)
DA662921   .c 515 to 1052 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DC424079 whole embryo, mainly head .c 524 to 1244 1 to 721   fully sequenced,   721/721
(100 %)
1 diff
(99.9 %id)
DA438084 tongue, tumor tissue .c 531 to 1064 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BI836456 pooled pancreas and spleen .c 535 to 1299 1 to 764       764/765
(99 %)
2 diff
(99.8 %id)
TI_57162618   .c 535 to 1299 34 to 797       764/798
(95 %)
2 diff
(99.8 %id)
BP350769   .c 551 to 1132 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_1948221530   .c 629 to 1222 724 to 132   fully sequenced,   593/724
(81 %)
1 diff
(99.9 %id)
AA371503 Prostate .c 652 to 841 1 to 190       190/190
(100 %)
0 diff
(100 %id)
TI_154053715   .c 663 to 1530 947 to 88   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 860/964
(89 %)
16 diff
(98.4 %id)
CX163436 human embryonic stem cells differentiated toan early endodermal cell type .c 689 to 1532 855 to 12     Submitted on the opposite strand 844/855
(98 %)
0 diff
(100 %id)
TI_154101180   .c 706 to 1530 902 to 79   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 824/824
(100 %)
11 diff
(98.7 %id)
BM904529 leiomyosarcoma, uterus .c 710 to 1529 886 to 57   AAA Submitted on the opposite strand 830/1059
(78 %)
27 diff
(97.5 %id)
EC501838 Prostate .c 716 to 816 1 to 101       101/101
(100 %)
0 diff
(100 %id)
BM679664 eye, fetal eye .c 788 to 1530 760 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 742/742
(100 %)
1 diff
(99.9 %id)
BQ773418 Chondrosarcoma Cell line .c 792 to 1530 757 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 739/739
(100 %)
2 diff
(99.8 %id)
CB529589 Aveolar Macrophage, lung .c 792 to 1530 757 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 739/739
(100 %)
3 diff
(99.6 %id)
CA427063 Bone, Subchondral Bone .c 793 to 1530 756 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 738/738
(100 %)
0 diff
(100 %id)
AA236128 germinal center B cell .c 803 to 971 169 to 1     Submitted on the opposite strand 169/169
(100 %)
0 diff
(100 %id)
FN064376 breast carcinoma .c 815 to 916 102 to 1     Submitted on the opposite strand 102/102
(100 %)
0 diff
(100 %id)
CX758982 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 815 to 1521 707 to 1       707/707
(100 %)
0 diff
(100 %id)
CX762101 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 836 to 1530 714 to 20   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 695/695
(100 %)
0 diff
(100 %id)
BQ026821 Chondrosarcoma, Left Pubic Bone .c 867 to 1530 682 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 664/665
(99 %)
0 diff
(100 %id)
CA421181 Bone, Enchondroma cell line .c 919 to 1530 630 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 612/612
(100 %)
0 diff
(100 %id)
CA441704 Chondrosarcoma, Left Pubic Bone .c 937 to 1530 612 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 594/594
(100 %)
0 diff
(100 %id)
BM667672 eye, fetal eyes .c 952 to 1530 597 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
BG057802 blood, lymphocyte .c 981 to 1530 550 to 1       550/550
(100 %)
0 diff
(100 %id)
AU159732   .c 987 to 1530 544 to 1       544/547
(99 %)
10 diff
(98.2 %id)
BE219336 carcinoid, lung .c 999 to 1529 531 to 1       531/531
(100 %)
0 diff
(100 %id)
AA634197 lung .c 1075 to 1500 426 to 1       426/426
(100 %)
0 diff
(100 %id)
DB517626 testis .c 1081 to 1530 1 to 450     Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
AW752554 colon .c 1128 to 1265 138 to 1       138/138
(100 %)
0 diff
(100 %id)
BG683870 brain, neuroblastoma, cell line .c 1176 to 1482 314 to 1   fully sequenced,   314/314
(100 %)
4 diff
(98.8 %id)
AA644235 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1192 to 1530 355 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 339/339
(100 %)
0 diff
(100 %id)
DC427014 whole embryo, mainly head .c 1211 to 1530 320 to 1   fully sequenced,   320/320
(100 %)
1 diff
(99.7 %id)
EH335470   .c 1290 to 1364 1 to 75       75/75
(100 %)
0 diff
(100 %id)
FN062169 breast carcinoma .c 1313 to 1431 1 to 119       119/119
(100 %)
0 diff
(100 %id)
AI382646 B-cell, chronic lymphotic leukemia .c 1344 to 1532 189 to 1   tiling clone,   189/189
(100 %)
0 diff
(100 %id)
FN055033 breast carcinoma .c 1380 to 1491 1 to 112       112/112
(100 %)
0 diff
(100 %id)
AI382629 B-cell, chronic lymphotic leukemia .c 1382 to 1532 151 to 1       151/151
(100 %)
0 diff
(100 %id)
BX647392 human colon endothel primary cell culture .d -9 to 3615 1 to 3626 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 3626/3626
(100 %)
6 diff
(99.9 %id)
AK226060 brain .d 55 to 3615 1771 to 5331 exact tiling clone,   3561/5331
(66 %)
0 diff
(100 %id)
BQ212308 embryonal carcinoma, cell line, testis .d 704 to 1472 1 to 777       777/876
(88 %)
14 diff
(98.5 %id)
DA351309 substantia nigra .d 1080 to 1664 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
CD653627 Embryonic Stem cells .d 1130 to 1905 12 to 782       771/795
(96 %)
10 diff
(98.8 %id)
BX477404   .d 1226 to 1693 38 to 506       469/506
(92 %)
0 diff
(100 %id)
CN285138 embryonic stem cells, cell lines H1, H7, andH9 .d 1276 to 1850 1 to 575       575/575
(100 %)
0 diff
(100 %id)
AA328563   .d 1300 to 1555 1 to 258       258/258
(100 %)
2 diff
(99.3 %id)
DA941948 Spleen .d 1380 to 1963 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BQ951235 sciatic nerve .d 1387 to 2199 12 to 831       820/967
(84 %)
9 diff
(99.1 %id)
AA333606 Embryo, 8 weeks .d 1397 to 1694 1 to 304       304/311
(97 %)
9 diff
(97.2 %id)
BE884622 leiomyosarcoma, uterus .d 1403 to 2048 1 to 650       650/835
(77 %)
12 diff
(98.6 %id)
DA371079 thalamus .d 1405 to 1974 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA174207 amygdala .d 1575 to 2114 2 to 544   capped   543/543
(100 %)
5 diff
(99.1 %id)
AA410245 ovarian tumor, ovary .d 1650 to 1978 328 to 1     Submitted on the opposite strand 328/328
(100 %)
1 diff
(99.7 %id)
DR760477 embryonic stem .d 1653 to 2448 1 to 796       796/796
(100 %)
0 diff
(100 %id)
BF802630 colon_ins .d 1741 to 2157 1 to 415       415/415
(100 %)
6 diff
(98.6 %id)
AW661781 pooled .d 1742 to 2091 354 to 4       351/354
(99 %)
0 diff
(100 %id)
DB249161 uterus .d 1815 to 2345 2 to 533   capped   532/532
(100 %)
3 diff
(99.5 %id)
AA338088 endometrium .d 1836 to 2094 1 to 259       259/259
(100 %)
0 diff
(100 %id)
DB533948 hippocampus .d 1842 to 2268 1 to 426     Submitted on the opposite strand 426/426
(100 %)
11 diff
(97.5 %id)
BF215478 brain, glioblastoma .d 1868 to 2435 1 to 574       574/574
(100 %)
15 diff
(97.4 %id)
BY993938   .d 1868 to 2509 29 to 670       642/670
(95 %)
0 diff
(100 %id)
AA300917 testis .d 1873 to 2091 1 to 219       219/219
(100 %)
1 diff
(99.6 %id)
CA503070 Human Lung Epithelial cells, lung .d 2049 to 2821 1 to 772     Submitted on the opposite strand 772/772
(100 %)
4 diff
(99.5 %id)
DB333242 Spleen .d 3085 to 3612 535 to 4       532/535
(99 %)
0 diff
(100 %id)
AK307958   .e 1 to 820 1 to 818   tiling clone,   818/818
(100 %)
1 diff
(99.9 %id)
DC348955   .e 1 to 571 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
DC364902   .e 1 to 547 1 to 547   tiling clone,   547/547
(100 %)
0 diff
(100 %id)
AA448112   .e 718 to 1165 448 to 1   tiling clone, Submitted on the opposite strand 448/448
(100 %)
3 diff
(99.4 %id)
DB507889 testis .e 755 to 1037 1 to 283     Submitted on the opposite strand 283/413
(68 %)
2 diff
(99.6 %id)
BF928203 nervous_tumor .e 765 to 979 221 to 2     Submitted on the opposite strand 220/236
(93 %)
4 diff
(98.4 %id)
EC559714 Prostate .e 801 to 905 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
EC546052 Prostate .e 805 to 905 13 to 114       102/114
(89 %)
0 diff
(100 %id)
AI218048 pooled .e 892 to 1037 145 to 1       145/145
(100 %)
2 diff
(98.7 %id)
AK293255   .f 1 to 1175 1 to 1175 exact tiling clone,   1175/1175
(100 %)
1 diff
(100.0 %id)
DC299410   .f 1 to 565 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BU597273 mixed (pool of 40 RNAs) .g 1 to 678 1 to 686 exact tiling clone, AAA   686/875
(78 %)
20 diff
(97.8 %id)
DA480170   .h 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
DN920368   .i-u 1 to 538 1 to 539 exact tiling clone,   539/539
(100 %)
5 diff
(99.1 %id)
258 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI